-
2
-
-
0012604746
-
Pregnancy and breast cancer
-
Donegan W L. Pregnancy and breast cancer. Obstet Gynecol. 50:1977;244-251.
-
(1977)
Obstet Gynecol
, vol.50
, pp. 244-251
-
-
Donegan, W.L.1
-
5
-
-
0028806049
-
Current status of endocrine therapy for metastatic breast cancer
-
Kimmick G, Muss H B. Current status of endocrine therapy for metastatic breast cancer. Oncology. 9:1995;877-890.
-
(1995)
Oncology
, vol.9
, pp. 877-890
-
-
Kimmick, G.1
Muss, H.B.2
-
6
-
-
0026557343
-
-
Lancet. 339:1992;1-15.
-
(1992)
Lancet
, vol.339
, pp. 1-15
-
-
-
7
-
-
0029794922
-
Endocrine therapies of breast cancer
-
Goldhirsch A, Gelber R D. Endocrine therapies of breast cancer. Semin Oncol. 23:1996;494-505.
-
(1996)
Semin Oncol
, vol.23
, pp. 494-505
-
-
Goldhirsch, A.1
Gelber, R.D.2
-
8
-
-
0029806829
-
-
Lancet. 348:1996;1189-1196.
-
(1996)
Lancet
, vol.348
, pp. 1189-1196
-
-
-
9
-
-
0028285865
-
Gonadotrophin-releasing hormone agonists
-
Filicori M. Gonadotrophin-releasing hormone agonists. Drugs. 48:1994;41-58.
-
(1994)
Drugs
, vol.48
, pp. 41-58
-
-
Filicori, M.1
-
10
-
-
0028224892
-
Ovarian function suppression with the gonadotrophin-releasing hormone (GnRH) analogue Goserelin in premenopausal advanced breast cancer
-
Bajetta E, Celio L, Zilembo N. Ovarian function suppression with the gonadotrophin-releasing hormone (GnRH) analogue Goserelin in premenopausal advanced breast cancer. Tumori. 80:1994;28-32.
-
(1994)
Tumori
, vol.80
, pp. 28-32
-
-
Bajetta, E.1
Celio, L.2
Zilembo, N.3
-
11
-
-
0028235123
-
The use of luteinizing hormone releasing hormone agonists and antagonists in gynacological cancers
-
Emons G, Schally A. The use of luteinizing hormone releasing hormone agonists and antagonists in gynacological cancers. Human Reproduction Update. 9:1994;1364-1379.
-
(1994)
Human Reproduction Update
, vol.9
, pp. 1364-1379
-
-
Emons, G.1
Schally, A.2
-
12
-
-
0026666819
-
Treatment of pre-menopausal advanced breast cancer with goserelin-a long-acting luteinizing hormore releasing hormone agonist
-
Brambilla C, Escobedo A, Artiolo R. Treatment of pre-menopausal advanced breast cancer with goserelin-a long-acting luteinizing hormore releasing hormone agonist. Anti-cancer drugs. 3:1992;3-8.
-
(1992)
Anti-cancer Drugs
, vol.3
, pp. 3-8
-
-
Brambilla, C.1
Escobedo, A.2
Artiolo, R.3
-
13
-
-
0024441013
-
Effect of treatment with gonadotropin-releasing hormone analogues on pregnancy outcome in the baboon
-
Kang I S, Kuehl T J, Siler-Khodr T M. Effect of treatment with gonadotropin-releasing hormone analogues on pregnancy outcome in the baboon. Fertil Steril. 52:1989;846-853.
-
(1989)
Fertil Steril
, vol.52
, pp. 846-853
-
-
Kang, I.S.1
Kuehl, T.J.2
Siler-Khodr, T.M.3
-
14
-
-
0028898752
-
Administration of a gonadotropin-releasing hormone agonist during pregnancy: Follow-up of 28 pregnancies exposed to triptoreline
-
Elefant E, Biour B, Blumberg J, Roux C, Thomas F. Administration of a gonadotropin-releasing hormone agonist during pregnancy: follow-up of 28 pregnancies exposed to triptoreline. Fertil Steril. 63:1995;1111-1113.
-
(1995)
Fertil Steril
, vol.63
, pp. 1111-1113
-
-
Elefant, E.1
Biour, B.2
Blumberg, J.3
Roux, C.4
Thomas, F.5
-
15
-
-
0027845505
-
Outcome of pregnancies inadvertently exposed to gonadotropin-releasing hormone analogues (GnRH-a) in early gestation
-
Gonen Y, Dirnfeld M, Abramovici H. Outcome of pregnancies inadvertently exposed to gonadotropin-releasing hormone analogues (GnRH-a) in early gestation. J Assist Reprod Genet. 10:1993;437-439.
-
(1993)
J Assist Reprod Genet
, vol.10
, pp. 437-439
-
-
Gonen, Y.1
Dirnfeld, M.2
Abramovici, H.3
-
16
-
-
0028263912
-
Multiple gestation following gonadotrophin releasing hormone therapy for the treatment of minimal endometriosis
-
Pickersgill A, Kingsland C R, Garden A S, Farquharson R G. Multiple gestation following gonadotrophin releasing hormone therapy for the treatment of minimal endometriosis. Br J Obs Gynaecol. 101:1994;260-262.
-
(1994)
Br J Obs Gynaecol
, vol.101
, pp. 260-262
-
-
Pickersgill, A.1
Kingsland, C.R.2
Garden, A.S.3
Farquharson, R.G.4
-
17
-
-
0027466623
-
GnRH agonist exposure during the first trimester of pregnancy
-
Young D C, Snabes M C, Poindexter A N. GnRH agonist exposure during the first trimester of pregnancy. Obs Gynecol. 81:1993;587-589.
-
(1993)
Obs Gynecol
, vol.81
, pp. 587-589
-
-
Young, D.C.1
Snabes, M.C.2
Poindexter, A.N.3
-
18
-
-
0025904740
-
The influence of inadvertent intranasal Buserelin administration in early pregnancy
-
Smitz J, Camus M, Devroey P. The influence of inadvertent intranasal Buserelin administration in early pregnancy. Hum Reprod. 6:1991;290-293.
-
(1991)
Hum Reprod
, vol.6
, pp. 290-293
-
-
Smitz, J.1
Camus, M.2
Devroey, P.3
-
19
-
-
0027409904
-
Internal jugular vein thrombosis during pregnancy after ovarian hyperstimulation for in vitro fertilization
-
Vauthier-Brozes D, Lefebvre G, Seebacher J, Wechsler B. Internal jugular vein thrombosis during pregnancy after ovarian hyperstimulation for in vitro fertilization. Contracept Fertil Sex. 21:1993;33-35.
-
(1993)
Contracept Fertil Sex
, vol.21
, pp. 33-35
-
-
Vauthier-Brozes, D.1
Lefebvre, G.2
Seebacher, J.3
Wechsler, B.4
-
20
-
-
0028235115
-
Outcome of inadvertent administration of a gonadotrophin-releasing hormone agonist (buserelin) in early pregnancy
-
Cahill D J, Fountain S A, Fox R. Outcome of inadvertent administration of a gonadotrophin-releasing hormone agonist (buserelin) in early pregnancy. Hum Reprod. 9:1994;1243-1246.
-
(1994)
Hum Reprod
, vol.9
, pp. 1243-1246
-
-
Cahill, D.J.1
Fountain, S.A.2
Fox, R.3
-
21
-
-
0028938629
-
Unexpected pregnancies exposed to Leuprolide acetate administered after the mid-luteal phase for ovarian stimulation
-
Chang S Y, Soong Y K. Unexpected pregnancies exposed to Leuprolide acetate administered after the mid-luteal phase for ovarian stimulation. Hum Reprod. 10:1995;204-206.
-
(1995)
Hum Reprod
, vol.10
, pp. 204-206
-
-
Chang, S.Y.1
Soong, Y.K.2
-
22
-
-
0029826580
-
Pregnancy during gonadotrophin- releasing hormone agonist therapy
-
Uncu G, Benderli S, Esmer A. Pregnancy during gonadotrophin- releasing hormone agonist therapy. Aus N Z J Obst Gynaecol. 36:1996;484-485.
-
(1996)
Aus N Z J Obst Gynaecol
, vol.36
, pp. 484-485
-
-
Uncu, G.1
Benderli, S.2
Esmer, A.3
-
23
-
-
0027421877
-
Gonadotropin-releasing hormone agonist administration in early human pregnancy is associated with normal outcomes
-
Wilshire G B, Emmi A M, Gagliardi C C, Weiss G. Gonadotropin-releasing hormone agonist administration in early human pregnancy is associated with normal outcomes. Fertil Steril. 60:1993;980-983.
-
(1993)
Fertil Steril
, vol.60
, pp. 980-983
-
-
Wilshire, G.B.1
Emmi, A.M.2
Gagliardi, C.C.3
Weiss, G.4
-
24
-
-
0025346984
-
Fetal outcome following inadvertent administration of long-acting DTRP GnRH microcapsules during pregnancy: A case report
-
Golan A, Ron-E1 R, Hermna A. Fetal outcome following inadvertent administration of long-acting DTRP GnRH microcapsules during pregnancy: a case report. Human Reproduction. 5:1990;123-124.
-
(1990)
Human Reproduction
, vol.5
, pp. 123-124
-
-
Golan, A.1
Ron-El, R.2
Hermna, A.3
-
25
-
-
0027459440
-
Pregnancy during long-term gonadotropin-releasing hormone agonist therapy associated with clinical menopause
-
Har-Toov J, Brenner S H, Jaffa A. Pregnancy during long-term gonadotropin-releasing hormone agonist therapy associated with clinical menopause. Fertil Steril. 59:1993;446-447.
-
(1993)
Fertil Steril
, vol.59
, pp. 446-447
-
-
Har-Toov, J.1
Brenner, S.H.2
Jaffa, A.3
|